431 related articles for article (PubMed ID: 29859856)
1. Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass.
Zhai H; Li Z; Peng M; Huang Z; Qin T; Chen L; Li H; Zhang H; Zhang W; Xu G
EBioMedicine; 2018 Jun; 32():201-214. PubMed ID: 29859856
[TBL] [Abstract][Full Text] [Related]
2. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
3. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
5. Gastric Mammalian Target of Rapamycin Signaling Contributes to Inhibition of Ghrelin Expression Induced by Roux-En-Y Gastric Bypass.
Li D; Li S; Pan Q; Zhai H; Peng M; Wang X; Xu G
Cell Physiol Biochem; 2018; 51(2):664-680. PubMed ID: 30463068
[TBL] [Abstract][Full Text] [Related]
6. Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice.
Hao Z; Leigh Townsend R; Mumphrey MB; Gettys TW; Yu S; Münzberg H; Morrison CD; Berthoud HR
Obes Surg; 2018 Oct; 28(10):3227-3236. PubMed ID: 29770924
[TBL] [Abstract][Full Text] [Related]
7. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
8. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
9. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.
Mazidi M; de Caravatto PP; Speakman JR; Cohen RV
Obes Surg; 2017 Mar; 27(3):826-836. PubMed ID: 28091894
[TBL] [Abstract][Full Text] [Related]
12. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
[TBL] [Abstract][Full Text] [Related]
13. Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Nielsen S; Svane MS; Kuhre RE; Clausen TR; Kristiansen VB; Rehfeld JF; Holst JJ; Madsbad S; Bojsen-Moller KN
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28202805
[TBL] [Abstract][Full Text] [Related]
14. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
Li W; Zhuang T; Wang Z; Wang X; Liu L; Luo Y; Wang R; Li L; Huang W; Wang Z; Yang L; Ding L
Phytomedicine; 2023 Oct; 119():154982. PubMed ID: 37531904
[TBL] [Abstract][Full Text] [Related]
15. Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.
Chaudhari SN; Harris DA; Aliakbarian H; Luo JN; Henke MT; Subramaniam R; Vernon AH; Tavakkoli A; Sheu EG; Devlin AS
Nat Chem Biol; 2021 Jan; 17(1):20-29. PubMed ID: 32747812
[TBL] [Abstract][Full Text] [Related]
16. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.
Kohli R; Bradley D; Setchell KD; Eagon JC; Abumrad N; Klein S
J Clin Endocrinol Metab; 2013 Apr; 98(4):E708-12. PubMed ID: 23457410
[TBL] [Abstract][Full Text] [Related]
17. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Katsuma S; Hirasawa A; Tsujimoto G
Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
[TBL] [Abstract][Full Text] [Related]
18. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
[TBL] [Abstract][Full Text] [Related]
19. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
20. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
